Reimbursement Subcommittee

Charter

The Reimbursement Subcommittee strives to:

  • Educate the cell therapy industry on pre-commercialization reimbursement considerations.
  • Identify and recruit leaders in industry who have late-stage development products and have addressed regulatory and manufacturing hurdles.

Projects and Objectives

  • Describe reimbursement policies on a regional basis to include the UK, Australia and USA.
  • Organize an ISCT webinar on reimbursement considerations.




 

Committee Members


                                                                    

 

Dawn Driscoll, PhD, MBA
Chair
DCi Biotech
Perth, Australia

Rui Bento, PharmD, MSc
Novartis
Porto Salvo, Portugal
Panos Kefalas, PhD, MBA
Cell Therapy Catapult
London, United Kingdom
Richard Maziarz, MD
Oregon Health and Science Universtiy
Portland, OR, United States
Francesco Paolucci, PhD
Murdoch University
Perth, Australia
Eric Strati, PharmD
Mesoblast
New York, NY, United States
 

© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.